Biological activities and health benefit effects of natural pigments derived from marine algae

Journal of Functional Foods

Volumn 3, Issue 4, 2011, Pages 255-266

  Pangestuti, Ratih ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

Author keywords

Anti inflammatory; Anticancer; Antioxidant; Marine algae; Natural pigments

Indexed keywords

ALGAE;

EID: 80052267548     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2011.07.001     Document Type: Review

References (118)

1. Abad M., Bedoya L., Bermejo P. Natural marine anti-inflammatory products. Mini Reviews in Medicinal Chemistry 2008, 8:740-754.
2. Abidov M., Ramazanov Z., Seifulla R., Grachev S. The effects of Xanthigen™ in the weight management of obese premenopausal women with non-alcoholic fatty liver disease and normal liver fat. Diabetes, Obesity and Metabolism 2010, 12:72-81.
3. Ansari J., Siraj A., Inamdar N. Pharmacotherapeutic approaches of Parkinson's disease. International Journal of Pharmacology 2010, 6:584-590.
4. Asai A., Sugawara T., Ono H., Nagao A. Biotransformation of fucoxanthinol into amarouxanthin a in mice and hepG2 cells: formation and cytotoxicity of fucoxanthin metabolites I. Drug Metabolism and Disposition 2004, 32:205-211.
5. Bjarkam C.R., Sørensen J.C., Sunde N.Å., Geneser F.A., Østergaard K. New strategies for the treatment of Parkinson's disease hold considerable promise for the future management of neurodegenerative disorders. Biogerontology 2001, 2:193-207.
6. Block M., Zecca L., Hong J. Microglia-mediated neurotoxicity: Uncovering the molecular mechanisms. Nature Reviews Neuroscience 2007, 8:57-69.
7. Bogorad L. Phycobiliproteins and complementary chromatic adaptation. Annual Review of Plant Physiology 1975, 26:369-401.
8. Bohn T. Bioavailability of non-provitamin A carotenoids. Current Nutrition and Food Science 2008, 4:240-258.
9. Burtin P. Nutritional value of seaweeds. Electronic Journal of Environmental, Agricultural and Food Chemistry 2003, 2:498-503.
10. Cahyana H. Antioxidative activity of porphyrin derivatives. Bioscience, Biotechnology, and Biochemistry 1993, 57:680-681.
11. Cahyana A.H., Shuto Y., Kinoshita Y. Pyropheophytin a as an antioxidative substance from the marine alga, arame (Eisenia bicyclis). Bioscience, Biotechnology, and Biochemistry 1992, 56:1533-1535.
12. Carmeliet P. Angiogenesis in health and disease. Nature Medicine 2003, 9:653-660.
13. Cho M.L., Lee H.S., Kang I.J., Won M.H., You S.G. Antioxidant properties of extract and fractions from Enteromorpha prolifera, a type of green seaweed. Food Chemistry 2011, 127:999-1006.
14. Cornish M., Garbary D. Antioxidants from macroalgae: Potential applications in human health and nutrition. Algae 2010, 25:155-171.
15. Curat C., Wegner V., Sengenes C., Miranville A., Tonus C., Busse R., et al. Macrophages in human visceral adipose tissue: Increased accumulation in obesity and a source of resistin and visfatin. Diabetologia 2006, 49:744-747.
16. Das S.K., Ren R., Hashimoto T., Kanazawa K. Fucoxanthin induces apoptosis in osteoclast-like cells differentiated from RAW264.7 cells. Journal of Agricultural and Food Chemistry 2010, 58:6090-6095.
17. Delgado-Vargas F., Jiménez A., Paredes-López O. Natural pigments: Carotenoids, anthocyanins, and betalains-Characteristics, biosynthesis, processing, and stability. Critical Reviews in Food Science and Nutrition 2000, 40:173-289.
18. Endo Y., Usuki R., Kaneda T. Antioxidant effects of chlorophyll and pheophytin on the autoxidation of oils in the dark. I. Comparison of the inhibitory effects. Journal of the American Oil Chemists' Society 1985, 62:1375-1378.
19. Endo Y., Usuki R., Kaneda T. Antioxidant effects of chlorophyll and pheophytin on the autoxidation of oils in the dark. II. The mechanism of antioxidative action of chlorophyll. Journal of the American Oil Chemists' Society 1985, 62:1387-1390.
20. Ferruzzi M.G., Blakeslee J. Digestion, absorption, and cancer preventative activity of dietary chlorophyll derivatives. Nutrition Research 2007, 27:1-12.
21. Ganesan P., Matsubara K., Ohkubo T., Tanaka Y., Noda K., Sugawara T., et al. Anti-angiogenic effect of siphonaxanthin from green alga, Codium fragile. Phytomedicine 2010, 17:1140-1144.
22. Ganesan P., Noda K., Manabe Y., Ohkubo T., Tanaka Y., Maoka T., et al. Siphonaxanthin, a marine carotenoid from green algae, effectively induces apoptosis in human leukemia (HL-60) cells. Biochimica et Biophysica Acta (BBA): General Subjects 2011, 1810:497-503.
23. Glazer A.N. Phycobiliproteins-A family of valuable, widely used fluorophores. Journal of Applied Phycology 1994, 6:105-112.
24. Hashimoto T., Ozaki Y., Taminato M., Das S., Mizuno M., Yoshimura K., et al. The distribution and accumulation of fucoxanthin and its metabolites after oral administration in mice. British Journal of Nutrition 2009, 102:242-248.
25. Hayato M., Masashi H., Tokutake S., Nobuyuki T., Teruo K., Kazuo M. Fucoxanthin and its metabolite, fucoxanthinol, suppress adipocyte differentiation in 3T3-L1 cells. International Journal of Molecular Medicine 2006, 18:147-152.
26. Hengartner M. The biochemistry of apoptosis. Nature 2000, 407:770-776.
27. Heo S.J., Hwang J.Y., Choi J.I., Han J.S., Kim H.J., Jeon Y.J. Diphlorethohydroxycarmalol isolated from Ishige okamurae, a brown algae, a potent α-glucosidase and α-amylase inhibitor, alleviates postprandial hyperglycemia in diabetic mice. European Journal of Pharmacology 2009, 615:252-256.
28. Heo S., Jeon Y. Protective effect of fucoxanthin isolated from Sargassum siliquastrum on UV-B induced cell damage. Journal of Photochemistry and Photobiology B: Biology 2009, 95:101-107.
29. Heo S., Ko S., Kang S., Kang H., Kim J., Kim S., et al. Cytoprotective effect of fucoxanthin isolated from brown algae Sargassum siliquastrum against H2O2-induced cell damage. European Food Research and Technology A 2008, 228:145-151.
30. Heo S.J., Yoon W.J., Kim K.N., Ahn G.N., Kang S.M., Kang D.H., et al. Evaluation of anti-inflammatory effect of fucoxanthin isolated from brown algae in lipopolysaccharide-stimulated RAW 264.7 macrophages. Food and Chemical Toxicology 2010, 48:2045-2051.
31. Hiqashi Okai K., Otani S., Okai Y. Potent suppressive effect of a Japanese edible seaweed, Enteromorpha prolifera (Sujiao-nori) on initiation and promotion phases of chemically induced mouse skin tumorigenesis. Cancer Letters 1999, 140:21-25.
32. Holdt S.L., Kraan S. Bioactive compounds in seaweed: Functional food applications and legislation. Journal of Applied Phycology 2011, 23:543-597.
33. Holt, S. (2008). Fucose complexes, fucoxanthin, fucoid and fat storage (pp. 87-92). Townsend letter.
34. Hosokawa M., Kudo M., Maeda H., Kohno H., Tanaka T., Miyashita K. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPAR γ-ligand, troglitazone, on colon cancer cells. Biochimica et Biophysica Acta (BBA): General Subjects 2004, 1675:113-119.
35. Hosokawa M., Miyashita T., Emi S., Tsukui T., Beppu F., Okada T., Miyashita K. Fucoxanthin regulates adipocytokine mRNA expression in white adipose tissue of diabetic/obese KK-Ay mice. Archives of Biochemistry and Biophysics 2010, 504:17-25.
36. Hosokawa M., Wanezaki S., Miyauchi K., Kurihara H., Kohno H., Kawabata J., et al. Apoptosis-inducing effect of fucoxanthin on human leukemia cell line HL-60. Food Science and Technology Research 1999, 5:243-246.
37. Ikeda K., Kitamura A., Machida H., Watanabe M., Negishi H., Hiraoka J., et al. Effect of Undaria pinnatifida (Wakame) on the development of cerebrovascular diseases in stroke prone spontaneously hypertensive rats. Clinical and Experimental Pharmacology and Physiology 2003, 30:44-48.
38. Ina A., Hayashi K., Nozaki H., Kamei Y. Pheophytin a, a low molecular weight compound found in the marine brown alga Sargassum fulvellum, promotes the differentiation of PC12 cells. International Journal of Developmental Neuroscience 2007, 25:63-68.
39. Ina A., Kamei Y. Vitamin B 12, a chlorophyll-related analog to pheophytin a from marine brown algae, promotes neurite outgrowth and stimulates differentiation in PC12 cells. Cytotechnology 2006, 52:181-187.
40. Inoue, S., Zimmet, P., Caterson, I., Chunming, C., Ikeda, Y., Khalid, A., Kim, Y., & Bassett, J. (2000). The Asia-Pacific perspective: Redefining obesity and its treatment (pp. 1-55). Health Communications Australia Pty Limited on behalf of the Steering Committee.
41. Ioannou, E., & Roussis, V. (2009). Natural products from seaweeds. In Plant-derived natural products (pp. 51-81). Springer-Verlag New York Inc.
42. Ishikawa C., Tafuku S., Kadekaru T., Sawada S., Tomita M., Okudaira T., et al. Antiadult T cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. International Journal of Cancer 2008, 123:2702-2712.
43. Je J.Y., Park P.J., Kim S.K. Antioxidant activity of a peptide isolated from Alaska pollack (Theragra chalcogramma) frame protein hydrolysate. Food Research International 2005, 38:45-50.
44. Kelishadi R. Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiologic Reviews 2007, 29:62-76.
45. Khan S., Kong C., Kim J., Kim S. Protective effect of Amphiroa dilatata on ROS induced oxidative damage and MMP expressions in HT1080 cells. Biotechnology and Bioprocess Engineering 2010, 15:191-198.
46. Khodosevich K., Monyer H. Signaling involved in neurite outgrowth of postnatally born subventricular zone neurons in vitro. BMC Neuroscience 2010, 11:18.
47. Kim K.N., Heo S.J., Yoon W.J., Kang S.M., Ahn G., Yi T.H., et al. Fucoxanthin inhibits the inflammatory response by suppressing the activation of NF-κB and MAPKs in lipopolysaccharide-induced RAW 264.7 macrophages. European Journal of Pharmacology 2010, 649:369-375.
48. Kim Y., Joh T. Microglia, major player in the brain inflammation: their roles in the pathogenesis of Parkinson's disease. Experimental and Molecular Medicine 2006, 38:333-347.
49. Kim S.K., Kim Y.T., Byun H.G., Nam K.S., Joo D.S., Shahidi F. Isolation and characterization of antioxidative peptides from gelatin hydrolysate of Alaska pollack skin. Journal of Agricultural and Food Chemistry 2001, 49:1984-1989.
50. Kim S.M., Shang Y.F., Um B.H. A preparative method for isolation of fucoxanthin from Eisenia bicyclis by centrifugal partition chromatography. Phytochemical Analysis 2011, 222:322-329.
51. Kim S., Wijesekara I. Development and biological activities of marine-derived bioactive peptides: A review. Journal of Functional Foods 2010, 2:1-9.
52. Kirk S., Frank J.A., Karlik S. Angiogenesis in multiple sclerosis: Is it good, bad or an epiphenomenon?. Journal of the Neurological Sciences 2004, 217:125-130.
53. Kong C.S., Kim J.A., Kim S.K. Anti-obesity effect of sulfated glucosamine by AMPK signal pathway in 3T3-L1 adipocytes. Food and Chemical Toxicology 2009, 47:2401-2406.
54. Kopelman P.G. Obesity as a medical problem. Nature 2000, 404:635-643.
55. Kotake Nara E., Asai A., Nagao A. Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells. Cancer Letters 2005, 220:75-84.
56. Kotake Nara E., Kushiro M., Zhang H., Sugawara T., Miyashita K., Nagao A. Carotenoids affect proliferation of human prostate cancer cells. Journal of Nutrition 2001, 131:3303.
57. Kotake Nara E., Terasaki M., Nagao A. Characterization of apoptosis induced by fucoxanthin in human promyelocytic leukemia cells. Bioscience, Biotechnology, and Biochemistry 2005, 69:224-227.
58. Lacey J.V., Devesa S.S., Brinton L.A. Recent trends in breast cancer incidence and mortality. Environmental and Molecular Mutagenesis 2002, 39:82-88.
59. Lanfer-Marquez U.M., Barros R., Sinnecker P. Antioxidant activity of chlorophylls and their derivatives. Food Research International 2005, 38:885-891.
60. Larkum A.W.D., Kühl M. Chlorophyll d: The puzzle resolved. Trends in Plant Science 2005, 10:355-357.
61. Le Tutour B., Benslimane F., Gouleau M., Gouygou J., Saadan B., Quemeneur F. Antioxidant and pro-oxidant activities of the brown algae, Laminaria digitata, Himanthalia elongata, Fucus vesiculosus, Fucus serratus and Ascophyllum nodosum. Journal of Applied Phycology 1998, 10:121-129.
62. Lee W.J., Koh E.H., Won J.C., Kim M.S., Park J.Y., Lee K.U. Obesity: The role of hypothalamic AMP-activated protein kinase in body weight regulation. The International Journal of Biochemistry and Cell Biology 2005, 37:2254-2259.
63. Maeda, H., Hosokawa, M., Sashima, T., & Miyashita, K. (2008). Antiobesity effect of fucoxanthin from edible seaweeds and its multibiological functions. In Functional food and health (pp. 376-388). ACS Publications.
64. Maeda H., Hosokawa M., Sashima T., Funayama K., Miyashita K. Fucoxanthin from edible seaweed, Undaria pinnatifida, shows antiobesity effect through UCP1 expression in white adipose tissues. Biochemical and Biophysical Research Communications 2005, 332:392-397.
65. Maeda H., Hosokawa M., Sashima T., Funayama K., Miyashita K. Effect of medium-chain triacylglycerols on anti-obesity effect of fucoxanthin. Journal of Oleo Science 2007, 56:615-621.
66. Maeda H., Hosokawa M., Sashima T., Miyashita K. Dietary combination of fucoxanthin and fish oil attenuates the weight gain of white adipose tissue and decreases blood glucose in obese/diabetic KK-Ay mice. Journal of Agricultural and Food Chemistry 2007, 55:7701-7706.
67. Maeda H., Hosokawa M., Sashima T., Murakami-Funayama K., Miyashita K. Anti-obesity and anti-diabetic effects of fucoxanthin on diet-induced obesity conditions in a murine model. Molecular Medicine Reports 2009, 2:897-902.
68. Matsuno T. Aquatic animal carotenoids. Fisheries Science 2001, 67:771-783.
69. Mokdad A., Ford E., Bowman B., Dietz W., Vinicor F., Bales V., et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. The Journal of the American Medical Association 2003, 289:76-79.
70. Narang S., Gibson D., Wasan A.D., Ross E.L., Michna E., Nedeljkovic S.S., et al. Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy. The Journal of Pain 2008, 9:254-264.
71. Ngo D.H., Wijesekara I., Vo T.S., Van Ta Q., Kim S.K. Marine food-derived functional ingredients as potential antioxidants in the food industry: An overview. Food Research International 2010, 44:523-529.
72. Ni Y., Wang L., Kokot S. Voltammetric determination of butylated hydroxyanisole, butylated hydroxytoluene, propyl gallate and tert-butylhydroquinone by use of chemometric approaches. Analytica Chimica Acta 2000, 412:185-193.
73. Nomura T., Kikuchi M., Kubodera A., Kawakami Y. Proton-donative antioxidant activity of fucoxanthin with 1,1-diphenyl-2-picrylhydrazyl (DPPH). IUBMB Life 1997, 42:361-370.
74. Okada T., Nakai M., Maeda H., Hosokawa M., Sashima T., Miyashita K. Suppressive effect of neoxanthin on the differentiation of 3T3-L1 adipose cells. Journal of Oleo Science 2008, 57:345-351.
75. Okai Y., Higashi Okai K. Pheophytin a is a potent suppressor against genotoxin induced umuC gene expression in Salmonella typhimurium (TA 1535/pSK 1002). Journal of the Science of Food and Agriculture 1997, 74:531-535.
76. Okai Y., Hiqashi Okai K. Potent anti-inflammatory activity of pheophytin a derived from edible green alga, Enteromorpha prolifera (Sujiao-nori). International Journal of Immunopharmacology 1997, 19:355-358.
77. Okai Y., Hiqashi Okai K., Yano Y., Otani S. Identification of antimutagenic substances in an extract of edible red alga, Porphyra tenera (Asadusa-nori). Cancer Letters 1996, 100:235-240.
78. Okuzumi J., Nishino H., Murakoshi M., Iwashima A., Tanaka Y., Yamane T., et al. Inhibitory effects of fucoxanthin, a natural carotenoid, on N-myc expression and cell cycle progression in human malignant tumor cells. Cancer Letters 1990, 55:75-81.
79. Pangestuti R., Kim S.K. Neuroprotective properties of chitosan and its derivatives. Marine Drugs 2010, 8:2117-2128.
80. Pangestuti R., Kim S.K. Neuroprotective effects of marine algae. Marine Drugs 2011, 9:803-818.
81. Park P., Jung W., Nam K., Shahidi F., Kim S. Purification and characterization of antioxidative peptides from protein hydrolysate of lecithin-free egg yolk. Journal of the American Oil Chemists' Society 2001, 78:651-656.
82. Pena-Ramos E., Xiong Y. Antioxidative activity of whey protein hydrolysates in a liposomal system. Journal of Dairy Science 2001, 84:2577-2583.
83. Pisani P., Bray F., Parkin D. Estimates of the world-wide prevalence of cancer for 25 sites in the adult population. International Journal of Cancer 2002, 97:72-81.
84. Pi-Sunyer F. The obesity epidemic: Pathophysiology and consequences of obesity. Obesity 2002, 10:97S-104S.
85. Ravi Kumar S., Narayan B., Vallikannan B. Fucoxanthin restrains oxidative stress induced by retinol deficiency through modulation of Na+ Ka+-ATPase and antioxidant enzyme activities in rats. European Journal of Nutrition 2008, 47:432-441.
86. Roh M.K., Uddin M.S., Chun B.S. Extraction of fucoxanthin and polyphenol from Undaria pinnatifida using supercritical carbon dioxide with co-solvent. Biotechnology and Bioprocess Engineering 2008, 13:724-729.
87. Sachindra N., Sato E., Maeda H., Hosokawa M., Niwano Y., Kohno M., et al. Radical scavenging and singlet oxygen quenching activity of marine carotenoid fucoxanthin and its metabolites. Journal of Agricultural and Food Chemistry 2007, 55:8516-8522.
88. Safer A., Al-Nughamish A. Hepatotoxicity induced by the anti-oxidant food additive, butylated hydroxytoluene (BHT), in rats: An electron microscopical study. Histology and Histopathology 1999, 14:391-406.
89. Sangeetha R., Bhaskar N., Baskaran V. Comparative effects of β-carotene and fucoxanthin on retinol deficiency induced oxidative stress in rats. Molecular and Cellular Biochemistry 2009, 331:59-67.
90. Sangeetha R., Bhaskar N., Divakar S., Baskaran V. Bioavailability and metabolism of fucoxanthin in rats: structural characterization of metabolites by LC-MS (APCI). Molecular and Cellular Biochemistry 2010, 333:299-310.
91. Sasaki K., Ishihara K., Oyamada C., Sato A., Fukushi A., Arakane T., et al. Effects of fucoxanthin addition to ground chicken breast meat on lipid and colour stability during chilled storage, before and after cooking. Asian-Australasian Journal of Animal Sciences 2008, 21:1067-1072.
92. Sasaki K., Ishihara K., Yamazaki M., Nakashima K., Abe H., Oyamada C., et al. Oral administration of fucoxanthin increases plasma fucoxanthinol concentration and antioxidative ability and improves meat color in broiler chicks. The Journal of Poultry Science 2010, 47:316-320.
93. Sekar S., Chandramohan M. Phycobiliproteins as a commodity: Trends in applied research, patents and commercialization. Journal of Applied Phycology 2008, 20:113-136.
94. Shahidi, F. (2008). Bioactives from marine resources. In ACS symposium series (pp. 24-34). ACS Publications.
95. Shahidi, F., & Alasalvar, C. (2011). Marine oils and other marine nutraceuticals. In Handbook of seafood quality, safety and health applications (pp. 444-454). Wiley Online Library.
96. Shahidi F., Janak Kamil Y. Enzymes from fish and aquatic invertebrates and their application in the food industry. Trends in Food Science and Technology 2001, 12:435-464.
97. Shang Y.F., Kim S.M., Lee W.J., Um B.H. Pressurized liquid method for fucoxanthin extraction from Eisenia bicyclis (Kjellman) Setchell. Journal of Bioscience and Bioengineering 2010, 111:237-241.
98. Shimoda H., Tanaka J., Shan S., Maoka T. Anti-pigmentary activity of fucoxanthin and its influence on skin mRNA expression of melanogenic molecules. Journal of Pharmacy and Pharmacology 2010, 62:1137-1145.
99. Shiratori K., Ohgami K., Ilieva I., Jin X.H., Koyama Y., Miyashita K., et al. Effects of fucoxanthin on lipopolysaccharide-induced inflammation in vitro and in vivo. Experimental Eye Research 2005, 81:422-428.
100. Sousa I., Batista A.P., Raymundo A., Empis J. Rheological characterization of coloured oil-in-water food emulsions with lutein and phycocyanin added to the oil and aqueous phases. Food Hydrocolloids 2006, 20:44-52.
101. Strand A., Herstad O., Liaaen-Jensen S. Fucoxanthin metabolites in egg yolks of laying hens. Comparative Biochemistry and Physiology - Part A: Molecular and Integrative Physiology 1998, 119:963-974.
102. Sugawara T., Baskaran V., Tsuzuki W., Nagao A. Brown algae fucoxanthin is hydrolyzed to fucoxanthinol during absorption by Caco-2 human intestinal cells and mice. The Journal of Nutrition 2002, 132:946-951.
103. Sugawara T., Matsubara K., Akagi R., Mori M., Hirata T. Antiangiogenic activity of brown algae fucoxanthin and its deacetylated product, fucoxanthinol. Journal of Agricultural and Food Chemistry 2006, 54:9805-9810.
104. Sugawara T., Yamashita K., Asai A., Nagao A., Shiraishi T., Imai I., et al. Esterification of xanthophylls by human intestinal Caco-2 cells. Archives of Biochemistry and Biophysics 2009, 483:205-212.
105. Swing J. What future for the oceans?. Foreign Affairs 2003, 82:139-152.
106. Terasaki M., Hirose A., Narayan B., Baba Y., Kawagoe C., Yasui H., et al. Evaluation of recoverable functional lipid components of several brown seaweeds (Phaeophyta) from Japan with special reference to fucoxanthin and fucosterol contents. Journal of Phycology 2009, 45:974-980.
107. Terry P., Rohan T., Wolk A. Intakes of fish and marine fatty acids and the risks of cancers of the breast and prostate and of other hormone-related cancers: A review of the epidemiologic evidence. American Journal of Clinical Nutrition 2003, 77:532-543.
108. Trayhurn P., Wood I.S. Signalling role of adipose tissue: Adipokines and inflammation in obesity. Biochemical Society Transactions 2005, 33:1078-1081.
109. Tsukui T., Baba N., Hosokawa M., Sashima T., Miyashita K. Enhancement of hepatic docosahexaenoic acid and arachidonic acid contents in C57BL/6J mice by dietary fucoxanthin. Fisheries Science 2009, 75:261-263.
110. Tsukui T., Konno K., Hosokawa M., Maeda H., Sashima T., Miyashita K. Fucoxanthin and fucoxanthinol enhance the amount of docosahexaenoic acid in the liver of KKAy obese/diabetic mice. Journal of Agriculture and Food Chemistry 2007, 55:5025-5029.
111. Tucci P., Bagetta G. How to study neuroprotection?. Cell Death and Differentiation 2008, 15:1084-1085.
112. Tutour B.L., Brunel C., Quemeneur F. Effet de synergie de la chlorophylle a sur les proprietes antioxydantes de la vitamine E. New Journal of Chemistry 1996, 20:707.
113. Wang T., Wang Y., Kontani Y., Kobayashi Y., Sato Y., Mori N., et al. Evodiamine improves diet-induced obesity in a uncoupling protein-1-independent manner: Involvement of antiadipogenic mechanism and extracellularly regulated kinase/mitogen-activated protein kinase signaling. Endocrinology 2008, 149:358-366.
114. Woo M.N., Jeon S.M., Shin Y.C., Lee M.K., Kang M.A., Choi M.S. Anti-obese property of fucoxanthin is partly mediated by altering lipid-regulating enzymes and uncoupling proteins of visceral adipose tissue in mice. Molecular Nutrition and Food Research 2009, 53:1603-1611.
115. Yabuta Y., Fujimura H., Kwak C.S., Enomoto T., Watanabe F. Antioxidant activity of the phycoerythrobilin compound formed from a dried Korean purple laver (Porphyra sp.) during in vitro digestion. Food Science and Technology Research 2010, 16:347-352.
116. Yan X., Chuda Y., Suzuki M., Nagata T. Fucoxanthin as the major antioxidant in Hijikia fusiformis, a common edible seaweed. Bioscience, Biotechnology, and Biochemistry 1999, 63:605-607.
117. Yuan Y., Walsh N. Antioxidant and antiproliferative activities of extracts from a variety of edible seaweeds. Food and Chemical Toxicology 2006, 44:1144-1150.
118. Zarros A. In which cases is neuroprotection useful?. Advance Alternatives Thinking Neurosciences 2009, 1:3-5.